Rahul Sachdeva
Overview
Explore the profile of Rahul Sachdeva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
330
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rempel L, Sachdeva R, Krassioukov A
Phys Med Rehabil Clin N Am
. 2024 Nov;
36(1):17-32.
PMID: 39567034
Autonomic dysfunctions are a major challenge to individuals following spinal cord injury. Despite this, these consequences receive far less attention compared with motor recovery. This review will highlight the major...
2.
Kalimullina T, Sachdeva R, Pawar K, Cao S, Marwaha A, Liu J, et al.
Exp Neurol
. 2024 Oct;
382:114993.
PMID: 39393671
Background And Objectives: Loss of supraspinal cardiovascular control and secondary damage following spinal cord injury (SCI) lead to cardiovascular dysfunction, where autonomic dysreflexia (AD), triggered by stimuli below the injury,...
3.
Sachdeva R, Rietchel L, Lee M, Krassioukov-Enns D, Ditunno J, Krassioukov A
Spinal Cord Ser Cases
. 2024 Jul;
10(1):45.
PMID: 38992024
No abstract available.
4.
Miller T, Hosseinzadeh A, Thordarson T, Kalimullina T, Samejima S, Shackleton C, et al.
JMIR Public Health Surveill
. 2024 Feb;
10:e50031.
PMID: 38393781
Background: Despite the growing accessibility of web-based information related to spinal cord stimulation (SCS), the content and quality of commonly encountered websites remain unknown. Objective: This study aimed to assess...
5.
Rempel L, Malik R, Shackleton C, Calderon-Juarez M, Sachdeva R, Krassioukov A
Toxins (Basel)
. 2024 Feb;
16(2).
PMID: 38393175
Since its regulatory approval over a half-century ago, botulinum toxin has evolved from one of the most potent neurotoxins known to becoming routinely adopted in clinical practice. Botulinum toxin, a...
6.
Calderon-Juarez M, Samejima S, Rempel L, Sachdeva R, Krassioukov A
World J Urol
. 2024 Feb;
42(1):80.
PMID: 38358540
Purpose: Spinal cord injury (SCI) leads to sensorimotor impairments; however, it can also be complicated by significant autonomic dysfunction, including cardiovascular and lower urinary tract (LUT) dysfunctions. Autonomic dysreflexia (AD)...
7.
Malik R, Samejima S, Shackleton C, Miller T, Pedrocchi A, Rabchevsky A, et al.
J Neural Eng
. 2024 Jan;
21(1).
PMID: 38271712
Electrical spinal cord stimulation (SCS) has emerged as a promising therapy for recovery of motor and autonomic dysfunctions following spinal cord injury (SCI). Despite the rise in studies using SCS...
8.
Calderon-Juarez M, Miller T, Samejima S, Shackleton C, Malik R, Sachdeva R, et al.
J Neurotrauma
. 2024 Jan;
41(9-10):1172-1180.
PMID: 38214089
Autonomic dysreflexia (AD) is a common autonomic complication of spinal cord injury (SCI) characterized by a sudden increase is blood pressure triggered by peripheral stimulation, such as bladder distention. Iatrogenic...
9.
Sachdeva R, Girshin K, Shirkhani Y, Gad P
Bioelectron Med
. 2024 Jan;
10(1):1.
PMID: 38167312
Regaining motor function in individuals with cerebral palsy (CP) has been predominantly studied in children, resulting in an underrepresentation of adults in research efforts. We tested the efficacy of noninvasive...
10.
Law M, Sachdeva R, Darrow D, Krassioukov A
Neuromodulation
. 2023 Sep;
27(7):1164-1176.
PMID: 37665302
Background And Objectives: There are many potential etiologies of impaired cardiovascular control, from chronic stress to neurodegenerative conditions or central nervous system lesions. Since 1959, spinal cord stimulation (SCS) has...